General information

Announcements(1)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Mon. Mar 17, 2025

Tue. Mar 18, 2025

Wed. Mar 19, 2025

web_header_en.png

web_icon.png

Profile management

Announcements

Bookmark

Program Type

Login required to view

Password required to view

Presentation Information

Session Details

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Targeted Protein Degraders in Eisai DHBL Drug Discovery

JPS : Academic Planning Committee for Annual Meeting

Drug development is undergoing a transformation from small molecules to medium molecules and a variety of other modalities. Pharmaceutical companies are making full use of these modalities to devise development strategies that are most effective for applicable diseases. At this symposium, pharmaceutical companies will report on their modality strategies. We believe that it will be an extremely meaningful opportunity for pharmaceutical companies to come together and hear about these modality strategies. What modalities are they considering, and for what diseases? We believe that we will be able to hear from pharmaceutical companies about the characteristics of modalities, the difficulty of development, and other aspects of their field.

Corporate Planning Symposium: Current status of R&D using strategic modalities in pharmaceutical companies

APPW2025

Presentation Information

[[OD]1S14a-3]Targeted Protein Degraders in Eisai DHBL Drug Discovery

Login required to view

Comment